TTS Pharma
Tom Atherton began their work experience in 2017 at Maillard's Estates as a Trainee Sales and later as a Trainee Sales Negotiator. In 2019, they joined Endopure and TTS Pharma as a Key Account Executive. The exact end dates for all positions are not provided.
Tom Atherton attended Canford School from 2010 to 2013. Following this, they enrolled at Lord Wandsworth College from 2013 to 2015. No degree or field of study information is provided for either school.
This person is not in any teams
TTS Pharma
TTS Pharma was formed in late 2012 to acquire Transdermal Technology & Systems (TTS) Limited as part of a strategic investment and corporate restructuring to prepare it for growth and to enable the group to undertake activities in both Europe and Asia. TTS Limited is a wholly owned subsidiary of TTS Pharma and undertakes its operatingactivities primarily in UK.